BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ueda M, Terai Y, Yamashita Y, Kumagai K, Ueki K, Yamaguchi H, Akise D, Hung Y, Ueki M. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer 2002;98:335-43. [DOI: 10.1002/ijc.10193] [Cited by in Crossref: 51] [Cited by in F6Publishing: 77] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Chen W, Huang S, Shi K, Yi L, Liu Y, Liu W. Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis. Cancer Control 2021;28:10732748211033743. [PMID: 34482737 DOI: 10.1177/10732748211033743] [Reference Citation Analysis]
2 Petrillo A, Laterza MM, Tirino G, Pompella L, Pappalardo A, Ventriglia J, Savastano B, Auricchio A, Orditura M, Ciardiello F, Galizia G, De Vita F. Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients. J Gastrointest Oncol 2019;10:314-23. [PMID: 31032100 DOI: 10.21037/jgo.2018.12.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Zhang J, Liu J, Zhu C, He J, Chen J, Liang Y, Yang F, Wu X, Ma X. Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis. Oncotarget 2017;8:24797-803. [PMID: 28177889 DOI: 10.18632/oncotarget.15044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
4 Samouëlian V, Revillion F, Alloy N, Lhotellier V, Leblanc E, Peyrat J. Measurement of mRNA of 11 Biomarkers by RT-PCR to Detect Lymph Node Involvement in Cervical Cancer. Int J Biol Markers 2008;23:74-82. [DOI: 10.1177/172460080802300203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zhang X, Xu R. Six1 expression is associated with a poor prognosis in patients with glioma. Oncol Lett 2017;13:1293-8. [PMID: 28454249 DOI: 10.3892/ol.2017.5577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
6 Deshpande R, Mansara P, Kaul-ghanekar R. Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines. Tumor Biol 2016;37:3295-305. [DOI: 10.1007/s13277-015-4170-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
7 Jalan S, Kanhaiya K, Rai A, Bandapalli OR, Yadav A. Network Topologies Decoding Cervical Cancer. PLoS One 2015;10:e0135183. [PMID: 26308848 DOI: 10.1371/journal.pone.0135183] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
8 Shang L, Zhao J, Wang W, Xiao W, Li J, Li X, Song W, Liu J, Wen F, Yue C. [Inhibitory effect of endostar on lymphangiogenesis in non-small cell lung cancer and its effect on circulating tumor cells]. Zhongguo Fei Ai Za Zhi 2014;17:722-9. [PMID: 25342038 DOI: 10.3779/j.issn.1009-3419.2014.10.03] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Tung MC, Hsieh MJ, Wang SS, Yang SF, Chen SS, Wang SW, Lee LM, Lee WJ, Chien MH. Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan. PLoS One 2014;9:e91147. [PMID: 24608123 DOI: 10.1371/journal.pone.0091147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
10 Xie LX, Zhai TT, Yang LP, Yang E, Zhang XH, Chen JY, Zhang H. Lymphangiogenesis and prognostic significance of vascular endothelial growth factor C in gastro-oesophageal junction adenocarcinoma. Int J Exp Pathol 2013;94:39-46. [PMID: 23317352 DOI: 10.1111/iep.12005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
11 Chen JC, Chang YW, Hong CC, Yu YH, Su JL. The role of the VEGF-C/VEGFRs axis in tumor progression and therapy. Int J Mol Sci 2012;14:88-107. [PMID: 23344023 DOI: 10.3390/ijms14010088] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
12 Wang CA, Jedlicka P, Patrick AN, Micalizzi DS, Lemmer KC, Deitsch E, Casás-Selves M, Harrell JC, Ford HL. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest 2012;122:1895-906. [PMID: 22466647 DOI: 10.1172/JCI59858] [Cited by in Crossref: 73] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
13 Wu EH, Yan M. Lymphangiogenesis in cancers: A therapy target. Shijie Huaren Xiaohua Zazhi 2011; 19(24): 2555-2561 [DOI: 10.11569/wcjd.v19.i24.2555] [Reference Citation Analysis]
14 Pasquali D, Santoro A, Bufo P, Conzo G, Deery WJ, Renzullo A, Accardo G, Sacco V, Bellastella A, Pannone G. Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation. Thyroid 2011;21:391-9. [PMID: 21385081 DOI: 10.1089/thy.2010.0168] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
15 Li Z, Qi F, Qi L, Zhang H, Chen M, Wang L, Zu X. VEGF-C as a decision-making biomarker for selected patients with invasive bladder cancer who underwent bladder-preserving radical surgery. Arch Med Res 2011;42:405-11. [PMID: 21821075 DOI: 10.1016/j.arcmed.2011.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
16 Shaker M, Yokoyama Y, Mori S, Tsujimoto M, Kawaguchi N, Kiyono T, Nakano T, Matsuura N. Aberrant expression of disintegrin-metalloprotease proteins in the formation and progression of uterine cervical cancer. Pathobiology 2011;78:149-61. [PMID: 21613802 DOI: 10.1159/000324314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 Li Z, Qi F, Miao J, Zu X, He W, Wang L, Qi L. Vascular Endothelial Growth Factor-C Associated with Computed Tomography Used in the Diagnosis of Lymph Node Metastasis of Bladder Carcinoma. Archives of Medical Research 2010;41:606-10. [DOI: 10.1016/j.arcmed.2010.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
18 He M, Cheng Y, Li W, Liu Q, Liu J, Huang J, Fu X. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade. BMC Cancer. 2010;10:170. [PMID: 20429915 DOI: 10.1186/1471-2407-10-170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
19 Kim Y, Friedman A. Interaction of Tumor with Its Micro-environment: A Mathematical Model. Bull Math Biol 2010;72:1029-68. [DOI: 10.1007/s11538-009-9481-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
20 Du Y, Zhang D, Liu H, Lai R. Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9. BMC Biotechnol 2009;9:84. [PMID: 19804631 DOI: 10.1186/1472-6750-9-84] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
21 Memtsas V, Zarros A, Theocharis S. Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach? Expert Opinion on Therapeutic Targets 2009;13:1105-20. [DOI: 10.1517/14728220903136767] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
22 Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Hung Y, Ueki M. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. Gynecological Endocrinology 2009;16:391-402. [DOI: 10.1080/gye.16.5.391.402] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
23 Yu X, Lo C, Lam AK, Lang BH, Leung P, Luk JM. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma. Surgery 2008;144:934-41. [DOI: 10.1016/j.surg.2008.07.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
24 Stacker SA, Achen MG. From Anti-Angiogenesis to Anti-Lymphangiogenesis: Emerging Trends in Cancer Therapy. Lymphatic Research and Biology 2008;6:165-72. [DOI: 10.1089/lrb.2008.1015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
25 Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Futakuchi H, Yamaguchi H, Yasuda M, Nishkama K, Ueki M. Tumor Angiogenesis and Molecular Target Therapy in Ovarian Carcinomas. Human Cell 2005;18:1-16. [DOI: 10.1111/j.1749-0774.2005.tb00052.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
26 Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci. 2008;1131:225-234. [PMID: 18519975 DOI: 10.1196/annals.1413.020] [Cited by in Crossref: 172] [Cited by in F6Publishing: 154] [Article Influence: 12.3] [Reference Citation Analysis]
27 Chechlinska M, Kowalska M, Kaminska J. Cytokines as potential tumour markers. Expert Opinion on Medical Diagnostics 2008;2:691-711. [DOI: 10.1517/17530059.2.6.691] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
28 Moon EJ, Brizel DM, Chi JT, Dewhirst MW. The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal 2007;9:1237-94. [PMID: 17571959 DOI: 10.1089/ars.2007.1623] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
29 Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007;14:1953-1967. [PMID: 17356953 DOI: 10.1245/s10434-006-9335-y] [Cited by in Crossref: 192] [Cited by in F6Publishing: 154] [Article Influence: 12.8] [Reference Citation Analysis]
30 Nagata S, Aishima S, Fukuzawa K, Takagi H, Yonemasu H, Iwashita Y, Kinoshita T, Wakasugi K. Adenomatoid tumour of the liver. J Clin Pathol 2008;61:777-80. [PMID: 18505892 DOI: 10.1136/jcp.2007.054684] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
31 Kito Y, Suzuki H. Electrophysiological properties of gastric pacemaker potentials. J Smooth Muscle Res. 2003;39:163-173. [PMID: 16843872 DOI: 10.1540/jsmr.39.163] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
32 Fujimiya M, Inui A. Peptidergic regulation of gastrointestinal motility in rodents. Peptides. 2000;21:1565-1582. [PMID: 16843872 DOI: 10.1016/S0196-9781(00)00313-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
33 Cowan KJ, Storey KB. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol. 2003;206:1107-1115. [PMID: 16843872 DOI: 10.1242/jeb.00220] [Cited by in Crossref: 389] [Cited by in F6Publishing: 393] [Article Influence: 24.3] [Reference Citation Analysis]
34 Engleman EG. Dendritic cell-based cancer immunotherapy. Semin Oncol. 2003;30:23-29. [PMID: 16843872 DOI: 10.1016/S0093-7754(03)00229-X] [Cited by in Crossref: 57] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
35 Ishikawa K, Komuro T, Hirota S, Kitamura Y. Ultrastructural identification of the c-kit-expressing interstitial cells in the rat stomach: a comparison of control and Ws/Ws mutant rats. Cell Tissue Res. 1997;289:137-143. [PMID: 16843872 DOI: 10.1007/s004410050859] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 3.0] [Reference Citation Analysis]
36 Takeda H, Yamakawa M, Takahashi T, Imai Y, Ishikawa M. An immunohistochemical study with an estrogen receptor- related protein (ER-D5) in human colorectal cancer. Cancer. 1992;69:907-912. [PMID: 16843872 DOI: 10.1002/1097-0142(19920215)69:4%3C907::AID-CNCR2820690412%3E3.0.CO;2-L] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Ohmori S, Shiraki K, Sugimoto K, Sakai T, Fujikawa K, Wagayama H, Takase K, Nakano T. High expression of CD34- positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol. 2001;32:1363-1370. [PMID: 16843872 DOI: 10.1053/hupa.2001.29678] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
38 Borecký J, Maia IG, Arruda P. Mitochondrial uncoupling proteins in mammals and plants. Biosci Rep. 2001;21:201-212. [PMID: 16843872 DOI: 10.1023/A:1013604526175] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
39 Angeh JE, Huang X, Sattler I, Swan GE, Dahse H, Härtl A, Eloff JN. Antimicrobial and anti-inflammatory activity of four known and one new triterpenoid from Combretum imberbe (Combretaceae). J Ethnopharmacol. 2007;110:56-60. [PMID: 16843872 DOI: 10.1016/j.jep.2006.09.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
40 Sutcliffe R, Maguire D, Murphy P, Portmann B, Rela M, O'Sullivan G, Mufti G, Heaton N. Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma. Transplantation. 2005;80:88-94. [PMID: 16843872 DOI: 10.1097/01.TP.0000164499.40952.C8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
41 Brown CJ, Falck VG, MacLean A. Angiosarcoma of the colon and rectum: report of a case and review of the literature. DisColon Rectum. 2004;47:2202-2207. [PMID: 16843872 DOI: 10.1007/s10350-004-0698-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
42 Gagliardi G, Bayar S, Smith R, Salem RR. Preoperative staging of rectal cancer using magnetic resonance imaging with external phase-arrayed coils. Arch Surg. 2002;137:447-451. [PMID: 16843872 DOI: 10.1001/archsurg.137.4.447] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
43 Esenwein SA, Martin D, Kuhnen C, Reimer R, Muhr G. [Retrogastral located gastrointestinal stromal tumor (GIST) as a sonographically detected rare incidental finding]. Zentralbl Chir. 2002;127:322-325. [PMID: 16843872 DOI: 10.1055/s-2002-31561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
44 Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology. 1998;33:318-324. [PMID: 16843872 DOI: 10.1046/j.1365-2559.1998.00522.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 6.9] [Reference Citation Analysis]
45 Takei Y, Okumura S, Nagal H. TNF-α induced apoptosis of hepatocyte precedes massive hepatic necrosis during the cause of acute hepatitis failure. Hepatology. 1995;22:380-390. [PMID: 16843872 DOI: 10.1016/0270-9139(95)95240-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Terada T, Ohta T, Nakanuma Y. Expression of oncogene products, anti-oncogene products and oncofetal antigens in intraductal papillary-mucinous neoplasm of the pancreas. Histopathology. 1996;29:355-361. [PMID: 16843872 DOI: 10.1111/j.1365-2559.1996.tb01419.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
47 Sharma R, Rajasekar MR, Raghuvanshi A. Immunosuppresion strategies after liver transplantation: a single centre experience in 57 liver transplan recipients. Indian J Surg. 2007;69:187-190. [PMID: 16843872 DOI: 10.1007/s12262-007-0018-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Bevilacqua S, Gallo M, Franco R, Rossi A, De Luca A, Rocco G, Botti G, Gridelli C, Normanno N. A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells. Lung Cancer. 2009;65:123-125. [PMID: 16843872 DOI: 10.1634/10.1016/j.lungcan.2009.01.019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Smith JA, Bhathal PS, Cuthbertson AM. Angiosarcoma of the colon. Report of a case with long-term survival. Dis Colon Rectum. 1990;33:330-333. [PMID: 16843872 DOI: 10.1007/BF02055479] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Wudel LJ Jr, Chapman WC. Indications and limitations of liver transplantation for hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:77-90, ix. [PMID: 16843872 DOI: 10.1016/S1055-3207(02)00092-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
51 Israel DA, Peek RM Jr. The role of persistence in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol. 2006;22:3-7. [PMID: 16843872 DOI: 10.1097/01.mog.0000194790.51714.f0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
52 Singh B, Sahu PM, Lohiya RK, Sharma MK, Singh HL, Singh S. Anti-inflammatory activity of alkanoids and triterpenoids from Trichodesma amplexicaule Roth. Phytomedicine. 2006;13:152-156. [PMID: 16843872 DOI: 10.1016/j.phymed.2004.06.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
53 Achen MG, Mann GB, Stacker SA. Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 2006;94:1355-60. [PMID: 16641900 DOI: 10.1038/sj.bjc.6603120] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 7.4] [Reference Citation Analysis]
54 Thiele W, Sleeman JP. Tumor-induced lymphangiogenesis: a target for cancer therapy? J Biotechnol. 2006;124:224-241. [PMID: 16497404 DOI: 10.1016/j.jbiotec.2006.01.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
55 Branca M, Giorgi C, Santini D, Di Bonito L, Ciotti M, Benedetto A, Paba P, Costa S, Bonifacio D, Di Bonito P, Accardi L, Favalli C, Syrjänen K; HPV-Pathogen ISS Study Group. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J Clin Pathol 2006;59:40-7. [PMID: 16394279 DOI: 10.1136/jcp.2005.026922] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
56 Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology 2006;43:373-4; author reply 375-6. [PMID: 16440359 DOI: 10.1002/hep.21019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
57 Van Trappen PO, Pepper MS. Lymphangiogenesis in human gynaecological cancers. Angiogenesis 2005;8:137-45. [PMID: 16211357 DOI: 10.1007/s10456-005-9008-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
58 Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell. 2005;7:121-127. [PMID: 15710325 DOI: 10.1016/j.ccr.2005.01.017] [Cited by in Crossref: 235] [Cited by in F6Publishing: 207] [Article Influence: 13.8] [Reference Citation Analysis]
59 Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer. 2005;103:724-730. [PMID: 15637689 DOI: 10.1002/cncr.20819] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.6] [Reference Citation Analysis]
60 Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, Ueki M. Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 2004;35:1369-75. [PMID: 15668894 DOI: 10.1016/j.humpath.2004.07.020] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
61 Stacker SA, Williams RA, Achen MG. Lymphangiogenic growth factors as markers of tumor metastasis. APMIS. 2004;112:539-549. [PMID: 15563315 DOI: 10.1111/j.1600-0463.2004.apm11207-0812.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
62 Srisomsap C, Sawangareetrakul P, Subhasitanont P, Panichakul T, Keeratichamroen S, Lirdprapamongkol K, Chokchaichamnankit D, Sirisinha S, Svasti J. Proteomic analysis of cholangiocarcinoma cell line. Proteomics. 2004;4:1135-1144. [PMID: 15048994 DOI: 10.1002/pmic.200300651] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
63 He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 2004;1654:3-12. [PMID: 14984763 DOI: 10.1016/j.bbcan.2003.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 49] [Article Influence: 0.7] [Reference Citation Analysis]
64 Allison KH, Yoder BJ, Bronner MP, Goldblum JR, Rubin BP. Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases. Am J Surg Pathol. 2004;28:298-307. [PMID: 15104292 DOI: 10.1097/00000478-200403000-00002] [Cited by in Crossref: 67] [Cited by in F6Publishing: 62] [Article Influence: 3.7] [Reference Citation Analysis]
65 Van Trappen PO, Steele D, Lowe DG, Baithun S, Beasley N, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper MS, Jackson DG, Sleeman JP, Jacobs IJ. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 2003;201:544-54. [PMID: 14648657 DOI: 10.1002/path.1467] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 5.2] [Reference Citation Analysis]
66 Ueda M, Hung Y, Term Y, Kanda K, Takehara M, Yamashita H, Yamaguchi H, Akise D, Yasuda M, Nishiyama K, Ueki M. Glutathione S-Transferase GSTM1, GSTT1 and p53 Codon 72 Polymorphisms in Human Tumor Cells. Human Cell 2003;16:241-51. [DOI: 10.1111/j.1749-0774.2003.tb00158.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
67 Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, Failla CM, Zambruno G. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 2003;98:789-97. [PMID: 12910524 DOI: 10.1002/cncr.11583] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 3.8] [Reference Citation Analysis]
68 Hoar F, Chaudhri S, Wadley M, Stonelake P. Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma. European Journal of Cancer 2003;39:1698-703. [DOI: 10.1016/s0959-8049(03)00382-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
69 Shen ZY, Xu LY, Chen MH, Li EM, Li JT, Wu XY, Zeng Y. Upregulated expression of Ezrin and invasive phenotype in malignantly transformed esophageal epithelial cells. World J Gastroenterol 2003; 9(6): 1182-1186 [PMID: 12800220 DOI: 10.3748/wjg.v9.i6.1182] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
70 Sauer G, Deissler H. Angiogenesis: prognostic and therapeutic implications in gynecologic and breast malignancies. Curr Opin Obstet Gynecol. 2003;15:45-49. [PMID: 12544501 DOI: 10.1097/00001703-200302000-00007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
71 Hung Y, Ueda M, Terai Y, Kumagai K, Ueki K, Kanda K, Yamaguchi H, Akise D, Ueki M. Homeobox gene expression and mutation in cervical carcinoma cells. Cancer Science 2003;94:437-41. [DOI: 10.1111/j.1349-7006.2003.tb01461.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
72 Baykal C, Ayhan A, Al A, Yüce K, Ayhan A. Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas. Gynecol Oncol 2003;88:123-9. [PMID: 12586590 DOI: 10.1016/s0090-8258(02)00073-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
73 Sawa H, Murakami H, Ohshima Y, Murakami M, Yamazaki I, Tamura Y, Mima T, Satone A, Ide W, Hashimoto I, Kamada H. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. Brain Tumor Pathol 2002;19:77-81. [DOI: 10.1007/bf02478931] [Cited by in Crossref: 48] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
74 Zimmerman RL, Burke MA, Young NA, Solomides CC, Bibbo M. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver. Cancer 2001;93:288-91. [DOI: 10.1002/cncr.9043] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 2.3] [Reference Citation Analysis]
75 Delvaux V, Sciot R, Neuville B, Moerman P, Peeters M, Filez L, Van Beckevoort D, Ectors N, Geboes K. Multifocal epithelioid angiosarcoma of the small intestine. Virchows Arch. 2000;437:90-94. [PMID: 10963385 DOI: 10.1007/s004280000183] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
76 Zoli M, Magalotti D, Giampaolo B, Gino G, Orlandini C, Grimaldi M, Marchesini G, Pisi E. Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. Journal of Hepatology 1995;23:129-34. [DOI: 10.1016/0168-8278(95)80326-2] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 1.8] [Reference Citation Analysis]